BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Lobular Breast Cancer Alliance - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Lobular Breast Cancer Alliance
X-ORIGINAL-URL:https://lobularbreastcancer.org
X-WR-CALDESC:Events for The Lobular Breast Cancer Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260715T120000
DTEND;TZID=America/New_York:20260715T130000
DTSTAMP:20260617T015151Z
CREATED:20260617T015151Z
LAST-MODIFIED:20260617T015151Z
UID:10000200-1784116800-1784120400@lobularbreastcancer.org
SUMMARY:Understanding Lobular Breast Cancer: Updates on Research\, Treatment\, Resources\, and Support
DESCRIPTION:LBCA Patient Advocate and Volunteer Treasurer\, Julie Ray\, will be one of two patient panelists on an Atrium Health webinar dedicated exclusively to lobular breast cancer — alongside fellow Local Advocacy Team (LAT) member Kathie Nejberger. An Atrium breast oncology professional will present the clinical science\, and Julie and Kathy will share the patient perspective. Below is a detailed explanation of the session. \n\nUnderstanding Lobular Breast Cancer: Updates on Research\, Treatment\, Resources\, and Support\n\nWednesday\, July 15\, 2026 · 12:00 pm – 1:00 pm EDT\n\n\n\nJoin Us for an Informative Online Session \nIf you have been diagnosed with invasive lobular carcinoma (ILC) breast cancer\, this session is designed for you. Learn how ILC differs from other breast cancer types\, what that means for detection and treatment\, and how current research is shaping care today and in the future. \nThis session is open to patients\, care partners\, staff\, and anyone who wants to better understand invasive lobular carcinoma breast cancer. You will hear from clinical experts as well as people affected by ILC\, offering both medical updates and lived experience. \nWhat Is Invasive Lobular Carcinoma (ILC)? \nInvasive lobular carcinoma (ILC) is a type of breast cancer that accounts for about 10–15% of breast cancer diagnoses in the United States. It begins in the lobules\, the milk‑producing glands of the breast\, and has the ability to spread into nearby breast tissue and beyond. \nILC cells tend to spread in thin lines rather than forming a firm lump. This pattern can make ILC harder to detect on routine imaging and may lead to diagnosis at a later stage than some other breast cancers. Symptoms can be subtle and may include breast fullness\, thickening\, or changes in breast shape rather than a distinct mass. ILC is also more likely to affect more than one area of the breast or\, in some cases\, both breasts. \nBecause much breast cancer research and education has focused on ductal cancer (IDC)\, some people with lobular breast cancer may feel that available information does not fully reflect their experience. As research grows\, care\, education\, and support for ILC continue to improve. \nWhy This Session Matters \nILC can go into remission\, especially when found and treated early. Some people reach complete remission\, while others may manage ILC over time with ongoing treatment. Therapies such as endocrine treatment or other medications may help control the disease\, reduce the risk of progression\, and support quality of life. \nBecause ILC may behave differently and may return later\, understanding long-term follow-up care is important. Staying informed about research and new treatment options can also help you make informed decisions about your care plan. \nWhat You’ll Learn \n\nHow ILC differs from other breast cancers and why it matters\nSymptoms\, detection challenges\, and imaging considerations\nUpdates on research and treatment\, including long‑term care\nInsights from people living with ILC\nQuestions to ask your care team\nSupport\, education\, and advocacy resources\n\n\nInstructors\n\n\n\n\n\n\n\n\nJenna Schlefman\, MD
URL:https://lobularbreastcancer.org/event/understanding-lobular-breast-cancer-updates-on-research-treatment-resources-and-support/
ATTACH;FMTTYPE=image/webp:https://lobularbreastcancer.org/wp-content/uploads/2026/06/2026-06-16_21-50-03.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260729T150000
DTEND;TZID=America/New_York:20260729T160000
DTSTAMP:20260723T205836Z
CREATED:20260723T205554Z
LAST-MODIFIED:20260723T205836Z
UID:10000202-1785337200-1785340800@lobularbreastcancer.org
SUMMARY:LBCA Liquid Biopsy Webinar #3: Liquid Biopsy in the Management and Monitoring of Metastatic ILC
DESCRIPTION:Please join us for the third webinar in a series focused on the emerging field of liquid biopsy and where the research is on use with patients diagnosed with ILC. This third session will focus on the use of these tools in the care of individuals living with a metastatic ILC diagnosis. We will hear from clinicians and researchers in the field who are focusing on this consistently evolving field.\n\nLBCA Scientific Advisory Board members Dr. Daniel Stover\, breast medical oncologist\, and Dr. Rita Mukhtar\, breast surgical oncologist will share where the current research stands\, what is currently standard of care\, and where their own research on this topic is focused in improving the monitoring of metastatic ILC. Dr. Carolina Reduzzi\, cancer biology researcher and prior LBCA grant recipient\, will share about her work on circulating tumor cells (CTCs) and what she is learning about this in the context of metastatic ILC. LBCA Patient Advocate Advisory Board Member Amy Russell-Parliman\, will share the patient’s perspective on the importance of research in this field and moderate the question and answer session at this event.\n\nWe look forward to having you join us for this educational webinar.\n\n\nRegister here.
URL:https://lobularbreastcancer.org/event/lbca-liquid-biopsy-webinar-3-liquid-biopsy-in-the-management-and-monitoring-of-metastatic-ilc/
ATTACH;FMTTYPE=image/webp:https://lobularbreastcancer.org/wp-content/uploads/2026/07/Liquid-Biopsy-webinar-4.webp
ORGANIZER;CN="Lobular Breast Cancer Alliance":MAILTO:info@lobularbreastcancer.org
END:VEVENT
END:VCALENDAR